Nalena Review
Best for: women-focused GLP-1-only platform with no membership or hidden fees
Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees. Its positioning leans on transparency: no hidden fees, cancel anytime, and a money-back guarantee uncommon among compounded providers. Pricing starts at $149/month with no insurance required and free 2-day shipping; clinical care is delivered by Beluga Health, P.A.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Nalena is a solid telehealth option with balanced features and pricing.
Nalena at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Nalena
Each dimension is scored algorithmically from Nalena’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $149/mo, Nalena runs about 12% below the $170 median for GLP-1 providers.
Effectiveness25%
8.0/10Nalena offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
8.2/10Nalena treats patients in all 50 states.
Support10%
5.8/10Nalena provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Nalena review
Last checked 2026-06-06- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Nalena offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Nalena's current pricing and active discounts before you decide.
What we like
- Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
- Transparent fee model: no hidden fees, no membership, cancel anytime
- Money-back guarantee — uncommon among compounded telehealths
- Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
- Women-focused positioning
- Free 2-day shipping
- Both compounded semaglutide and tirzepatide offered
Watch-outs
- Per-dose pricing not published — only the 'starting at $149' entry price
- No LegitScript, HIPAA, or NABP badges on public pages
- Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
- Houston address looks like a virtual office rather than a clinical facility
- No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
- Women-focused framing may under-serve male patients
- Texas patients may face licensure friction since Beluga Health is incorporated in Florida
Nalena: a women-first, all-inclusive GLP-1 price near the compounded floor
Nalena is a deliberately narrow service: it does one thing, which is compounded GLP-1 weight loss for women, and it bundles everything into a single monthly number. There is no membership, no separate visit fee, and no surprise add-on at checkout. Medication, the clinical consult, and shipping are all folded into the headline rate of $149/month to start. If you want a no-frills, transparent, all-in price and you don't care about brand-name pens or a fancy app, Nalena is worth a serious look. If you want named pharmacies, posted per-dose pricing, or visible accreditation badges before you hand over a card, you'll find the gaps frustrating.
How the pricing actually works (and where it gets fuzzy)
The model is refreshingly simple on the surface: one bundled price that includes the semaglutide or tirzepatide, the prescription, and free two-day shipping, with no insurance required. That starting rate of $149/month sits close to the bottom of the compounded market and below the category median of about $170/month, so on a pure cost basis Nalena is genuinely competitive.
The catch is the word *starting*. Nalena publishes only the entry price; it does not post a per-dose ladder showing what you'll pay as your dose climbs over the months. With compounded GLP-1s, the dose typically increases through titration, and many providers charge more at higher doses. Because Nalena doesn't lay that out publicly, you can't see your month-six cost before signing up — you have to take the intro number on faith and confirm the rest during onboarding. It also does not run a discounted teaser first-month rate, so the price you see is roughly the price you start paying.
The money-back guarantee is the real standout
What actually sets Nalena apart from the crowd of look-alike compounded telehealths is its money-back guarantee. That is uncommon in this corner of the market — most compounded sellers treat the sale as final once the vial ships. Paired with a true cancel-anytime policy and an explicit no-hidden-fees promise, the guarantee meaningfully lowers the risk of trying the service. For a first-time GLP-1 patient who isn't sure the medication will agree with them, that safety net is the single best reason to pick Nalena over a cheaper-by-a-few-dollars rival.
The medications and how they're dispensed
Nalena offers two products: compounded semaglutide (the molecule in Ozempic and Wegovy) and compounded tirzepatide (the molecule in Mounjaro and Zepbound). Both are injectables. There are no oral options and — importantly — no brand-name pens. If you specifically want FDA-approved Wegovy or Zepbound, Nalena is not your provider; it is compounded-only.
That distinction matters for safety expectations. Nalena's own site is upfront about it, stating that compounded GLP-1s are made in FDA-regulated facilities but are *not* FDA-approved or evaluated for safety, efficacy, or quality. That is an honest disclosure and the correct legal framing, but it's also a reminder that compounded products don't carry the same regulatory backing as the branded drugs. See our scoring methodology for how we weigh compounded-only offerings.
Who's actually behind the prescriptions
Clinical care is delivered by Beluga Health, P.A., listed as a Florida Professional Association operating from a Houston, Texas address. Disclosing the prescribing entity by name is a point in Nalena's favor — plenty of competitors hide who writes the scripts. The wrinkle is that the Houston address reads more like a virtual office than a brick-and-mortar clinic, and because Beluga is incorporated in Florida, Texas patients in particular may run into licensure friction. It's not a red flag on its own, but it's worth knowing the clinical brand and the mailing address don't tell a tidy story.
Trust and safety: disclosed where it counts, missing where it matters
This is where we'd want more from Nalena. The compounding pharmacies are not named — the site only says it works with "multiple USA certified pharmacies," which gives you no way to check accreditation yourself. There are also no LegitScript, HIPAA, or NABP badges displayed on the public pages. None of that proves anything is wrong; our review found no FDA warning letters on file against Nalena. But the absence of named pharmacies and visible accreditation means our verification confidence here is moderate rather than high. You're trusting the brand and its honest disclaimers more than independently verifiable credentials.
- Disclosed: the prescribing entity (Beluga Health, P.A.), the compounded-only nature of the drugs, and a candid FDA-status disclaimer.
- Not disclosed: the actual compounding pharmacies, and any LegitScript / HIPAA / NABP accreditation.
- No FDA warnings on file, but verification confidence is capped by the missing pharmacy and accreditation details.
Who should choose Nalena — and who should skip it
Choose Nalena if you're a woman who wants the lowest realistic all-in price on compounded semaglutide or tirzepatide, values a money-back guarantee and cancel-anytime terms, and is comfortable with compounded medication. The bundled pricing and free two-day shipping across 49 states make it an easy, low-commitment on-ramp.
Skip it if you want brand-name GLP-1s, need to see your full per-dose cost before committing, or you specifically want named pharmacies and posted accreditation. Male patients should also note the explicitly women-focused framing — the service may technically serve you, but the experience isn't built around you. And Texas residents should confirm coverage given the Florida-incorporated clinical provider.
Bottom line
Nalena is one of the more honest budget plays in compounded GLP-1 telehealth: a single transparent price near the market floor, everything included, a genuine money-back guarantee, and a named prescriber. It loses points for the things it doesn't show you — per-dose pricing, the pharmacies, and accreditation badges. If a low all-in cost and a real refund safety net top your list, Nalena earns a spot on your shortlist; just go in expecting to confirm the higher-dose pricing and the pharmacy details during sign-up rather than reading them off the homepage.
For a side-by-side, Yucca Health ($146/month) and DudeMeds ($149/month) are the most comparable options to weigh against Nalena.
Ready to start with Nalena?
Starting at $149/month. See current pricing and start your free consultation.
Alternatives to Nalena
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nalena review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Nalena?
Starting at $149/month. See current pricing and start your free consultation.